Peptonic has entered an agreement to acquire a majority of the shares in Lune Group Oy and the board intends to resolve on a share issue of 19.2 MSEK and directed share issue of 7.5 MSEK
Stockholm, May 14[th] 2020 - Peptonic Medical AB (publ) (“Peptonic” or the “Company”) has today entered into an agreement to acquire a majority of the shares in Lune Group Oy (“Lune”), a Finnish company that sells the Lunetteâ menstrual cup. The transaction entails that Peptonic acquires 60 percent of the existing shares from the current shareholders against a purchase price of approx. 1.80 MEUR, corresponding to approx. 19.2 MSEK (exchange rate 10.64). The purchase price shall be paid in the form of newly issued shares in Peptonic. The completion of the acquisition of the existing shares is